drugset

drugset / Trial / NCT05999292

Phase 1 Study of 68Ga-R8760

NCT05999292 ↗

Phase 1 Terminated 11 enrolled Radionetics Oncology

Non-randomizedSequentialOpen-labelDiagnostic

Summary

A Phase 1 Safety and Dosimetry Study of 68Ga-R8760 in Patients with Adrenocortical Carcinoma and Healthy Volunteers

Timeline

Start: 2023-09-11
Primary completion: 2024-05-23
Completion: 2024-05-23

Outcome

Outcome not reported

Stopped (Business): “Sponsor decision”

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	68Ga-R8760	Unknown	—	—

Indications